RUTISS-Diary and RUTISS-65 Study
NCT07698041 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-07-13
Summary
Existing patient-reported outcome measures assess acute urinary tract infection but do not support daily symptom tracking in recurrent UTI (rUTI) or meet the needs of older adults. This single-site study will develop and validate two adapted measures: the RUTISS-Diary for daily symptom monitoring and the RUTISS-65 for reporting symptoms in adults aged 65 years and over. Approximately 200 participants with rUTI will complete the RUTISS-Diary daily for 7 days and again on day 14. Participants aged 65 years and over will also complete the RUTISS-65 on days 1 and 2 to assess its reliability and validity.
Conditions
- Urology
- Urological Diseases
- Patient Satisfaction
- Pain, Chronic
Interventions
- OTHER
-
Non-interventional Patient Reported Outcome Measure Development (RUTISS-Diary)
RUTISS-Diary
- OTHER
-
Non-interventional Patient Reported Outcome Measure Development (RUTISS-65)
RUTISS-65
Sponsors & Collaborators
-
Royal Berkshire NHS Foundation Trust
collaborator OTHER_GOV -
Katherine Finlay
lead OTHER
Principal Investigators
-
Katherine A Finlay, PhD, CPsychol · University of Reading
-
Bob Yang, FRCS (UROL), MBBS, BSC (HONS) · Royal Berkshire NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-08
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-24
Countries
- United Kingdom
Study Locations
More Related Trials
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study
NCT03808038 ·Status: COMPLETED
-
The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST
NCT02444975 ·Status: COMPLETED ·Phase: NA
-
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
NCT02410135 ·Status: COMPLETED
-
COVID-19 Vaccines and the Development of New LUTS
NCT05582525 ·Status: COMPLETED
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.
NCT03575702 ·Status: COMPLETED ·Phase: PHASE3
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.
NCT00141128 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
NCT07025044 ·Status: RECRUITING
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
NCT06351683 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
NCT00304499 ·Status: COMPLETED ·Phase: PHASE3
-
Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.
NCT01282840 ·Status: COMPLETED ·Phase: NA
-
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
NCT06059066 ·Status: COMPLETED ·Phase: NA
-
Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
NCT01657409 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder
NCT00171184 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of LiRIS in Interstitial Cystitis (IC) Patients
NCT01150565 ·Status: COMPLETED ·Phase: PHASE1
-
Bladder Botox UTI Antibiotic Prophylaxis
NCT06387329 ·Status: RECRUITING ·Phase: PHASE4
-
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
NCT00368706 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
NCT06024005 ·Status: COMPLETED ·Phase: NA
-
Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms
NCT01595152 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria
NCT00969254 ·Status: UNKNOWN ·Phase: PHASE3
-
Reduced-dose Botox for Urgency Incontinence Among Elder Females
NCT05512039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain
NCT03003845 ·Status: COMPLETED